About 20 Mg Octreotide For Injection
Experience elite efficacy with our 20 Mg Octreotide For Injection, now offered at a special rate for limited-time sale. This pristine, single-dose vial delivers a gilt-edged solution for acromegaly and gastroenteropancreatic neuroendocrine tumors. With perfect manufacturing integrity, each pack includes a securely boxed vial with leaflet, reconstituted with 5 mL sterile water to ensure optimal solubility. Octreotide Acetate meets rigorous USP Grade standards and is suitable for IM or SC injection. Batch and expiry information are clearly printed for reference. Shelf life spans 24 months under recommended storage.
Elite Therapeutic Performance & Targeted Application
20 Mg Octreotide For Injection is highly favored by healthcare professionals for managing acromegaly, carcinoid tumors, VIPomas, and neuroendocrine disorders. Extra features include long-acting, highly purified lyophilized powder with somatostatin analogue activity. Its specific usage allows for both intramuscular and subcutaneous administration, providing clinicians flexibility in patient care. Pristine formulation and USP quality guarantee gilt-edged results for diverse hospital and clinical settings.
Reliable Supply, Swift Handover & Recognized Quality
Our supply ability ensures consistent availability of 20 Mg Octreotide For Injection for distributors, exporters, and healthcare traders across India. Order completion and exchange are processed with meticulous speed, typically ensuring quick delivery times. Each handover is backed by certifications meeting stringent US Pharmacopeia standards. Product documentation includes licensing details on request, ensuring every transaction is seamless and trustworthy for medical procurement needs.
FAQ's of 20 Mg Octreotide For Injection:
Q: How should 20 Mg Octreotide For Injection be reconstituted before use?
A: Reconstitute the lyophilized powder with 5 mL of sterile water for injection, ensuring complete dissolution before administration.
Q: What is the main benefit of using this gilt-edged Octreotide injectable formulation?
A: It provides highly purified, long-acting somatostatin analogue activity, ensuring effective management of acromegaly and neuroendocrine tumors with USP-grade assurance.
Q: When is this injection recommended for patient treatment?
A: It is recommended for treating conditions such as acromegaly, gastroenteropancreatic neuroendocrine tumors, carcinoid tumors, and VIPomas after clinician assessment.
Q: Where can batch number and expiry date information be found?
A: Batch numbers are printed on the packaging, and expiry dates are clearly marked on both the vial and carton for user reference.
Q: What is the preferred route of administration for 20 Mg Octreotide?
A: This product is suitable for intramuscular or subcutaneous injection, allowing flexibility based on therapeutic requirements.
Q: How should the product be stored to maintain its pristine quality?
A: Store below 25C, protect from light, and ensure it remains odorless, securing a shelf life of 24 months.